Safe and effective vaccine against Clostridium perfringens in poultry
The vaccine consists of a combination of recombinant NetB and alpha-toxin, both detoxified.
C. perfringens infections in poultry may present as an acute clinical disease, with high mortality at 2 to 5 weeks of age, or in a subclinical form leading to reduced weight gain which costs the worldwide poultry industry 2 billion USD annually (or 0,05USD per bird)
Proof of concept in target species (Ross308 broilers)
Immunisation with NetB- and alpha-toxoid reduced lesion scores completely. None of the animals vaccinated with a combination of NetB and CPA developed necrotic enteritis lesions after challenge.
A recombinant vaccine based on toxoids of NetB and alfatox fit for vaccination of chickens against Clostridium perfringens.
· Contact name
Sven Arnouts
· E-mail
sven.arnouts@ugent.be
· Phone
+32 495 707 334
· Partner sought:
Partnering
We are looking for partners that are interested to market the vaccine and we are open to assist during the transfer of the technology and during the development phase.
A recombinant vaccine based on toxoids of NetB and alfatox fit for vaccination of chickens against Clostridium perfringens.
Sven Arnouts
sven.arnouts@ugent.be
+32 495 707 334
en
ES